EVOKE PHARMA, INC. Accounts Payable and Accrued Liabilities, Noncurrent
EVOKE PHARMA, INC. had Accounts Payable and Accrued Liabilities, Noncurrent of $1.61 million as of 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:AccountsPayableAndAccruedLiabilitiesNoncurrent · last filed 2024-05-14
- 2023-12-31: Accounts Payable and Accrued Liabilities, Noncurrent $1.61M.
- 2023-09-30: Accounts Payable and Accrued Liabilities, Noncurrent $1.49M.
- 2023-06-30: Accounts Payable and Accrued Liabilities, Noncurrent $1.36M.
- 2023-03-31: Accounts Payable and Accrued Liabilities, Noncurrent $1.24M.
| Period end | Accounts Payable and Accrued Liabilities, Noncurrent |
|---|---|
| 2023-12-31 | $1.61M 10-K · filed 2024-03-14 |
| 2023-09-30 | $1.49M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.36M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.24M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.11M 10-K/A · filed 2024-05-14 |
| 2022-09-30 | $986.27K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $860.24K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $735.58K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $612.29K 10-K · filed 2023-03-21 |
| 2021-09-30 | $486.27K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $360.24K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $235.58K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $112.99K 10-K · filed 2022-03-08 |
| 2020-09-30 | $53.01K 10-Q · filed 2020-11-10 |